Science Spyglass GLP-1 receptor assay: drug discovery in the metabolic disorders field Metabolic disorders , particularly type 2 diabetes and obesity , represent a major global health burden
Blockade of CRF(1) or V(1b) receptors reverses stress-induced suppression of neurogenesis in a mouse model of depression
If youre taking diabetes medications, please discuss this with your prescribing doctor before starting a GLP-1, as your diabetes medications may need to be adjusted as you lose weight
By targeting different pathways involved in appetite regulation and metabolism, these medications can address multiple aspects of obesity and diabetes simultaneously
Your insurer wants a formulary check, ICD-10 diagnosis (E66.9 or E11.9), documented step-therapy failures, and a letter of medical necessity
The L cells are stimulated by a range of metabolites, including dietary, microbial, and endogenous molecules to produce short-chain fatty acids (SCFAs)